Related Experiment Video

Updated: May 7, 2026

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies
08:16

Partial Sciatic Nerve Ligation: A Mouse Model of Chronic Neuropathic Pain to Study the Antinociceptive Effect of Novel Therapies

Published on: October 6, 2022

Involvement of protease-activated receptor 2 in nociceptive behavior in a rat model of bone cancer

Yanju Bao1, Baojin Hua, Wei Hou

  • 1Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beixiange 5, Xicheng, Beijing, 100053, China, baoyanju@126.com.

Journal of Molecular Neuroscience : MN
|September 24, 2013
PubMed

Insights

Protease-activated receptor 2 (PAR2) is upregulated in bone cancer pain, contributing to mechanical allodynia and thermal hyperalgesia. Blocking PAR2 alleviates these pain behaviors, suggesting it as a potential therapeutic target.

Area of Science:

  • Neuroscience
  • Oncology
  • Pain Research

Background:

  • Bone cancer pain presents a significant clinical challenge due to poorly understood mechanisms.
  • Protease-activated receptor 2 (PAR2) is involved in pain signaling, but its role in bone cancer pain is unclear.

Purpose of the Study:

  • To investigate the role of PAR2 in a rat model of bone cancer pain.
  • To determine if PAR2 antagonism can alleviate pain behaviors associated with bone cancer.

Main Methods:

  • Bone cancer pain was induced in rats using Walker 256 inoculation.
  • Pain behaviors were assessed using mechanical allodynia, thermal hyperalgesia, and spontaneous nocifensive behavior tests.
  • PAR2 expression in dorsal root ganglia (DRG) neurons was examined via immunohistochemistry.

Main Results:

  • Rats with bone cancer displayed significant mechanical allodynia, thermal hyperalgesia, and spontaneous pain.
  • Administration of a PAR2 antagonist (FSLLRY-NH2) abolished mechanical allodynia and thermal hyperalgesia.
  • PAR2 expression was significantly increased in large- and medium-sized DRG neurons of rats with bone cancer.

Conclusions:

  • Increased PAR2 expression in DRG neurons contributes to mechanical allodynia and thermal hyperalgesia in bone cancer pain.
  • PAR2 represents a potential novel therapeutic target for managing bone cancer pain.

More Related Videos

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior12:20

Use of the Operant Orofacial Pain Assessment Device (OPAD) to Measure Changes in Nociceptive Behavior

Published on: June 10, 2013

Related Concept Videos

Nociception01:44

Nociception

Nociception—the ability to feel pain—is essential for an organism’s survival and overall well-being. Noxious stimuli such as piercing pain from a sharp object, heat from an open flame, or contact with corrosive chemicals are first detected by sensory receptors, called nociceptors, located on nerve endings. Nociceptors express ion channels that convert noxious stimuli into electrical signals. When these signals reach the brain via sensory neurons, they are perceived as pain. Thus, pain helps the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...